Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...

The tracker allows patients to self-identify, provide their location, and say which brand of GLP-1 drug they are not able to ...

Examples include dulaglutide ... [5] Dulaglutide: A type of glucagon-like peptide-1 (GLP-1) receptor agonist approved by the ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Eli Lilly and its investors this past week learned a hard lesson: The sky is no longer the limit when it comes to sales of its blockbuster glucagon-like peptide 1 (GLP-1) drugs for diabetes and ...

If you had come across the abbreviation GLP-1 a few years ago, chances are you’d have had no idea what it stood for. Intro to Greek lyric poetry? Low-level Great Lakes precipitation? A member of the ...

Originally intended as a treatment for diabetes, GLP-1 drugs like Ozempic could be set to turn the food and drink industry ...

In Parkinson’s disease, for example, GLP-1 drugs may reduce brain inflammation and improve mitochondrial function, which could explain the observed improvements in motor abilities . Meanwhile ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...

Over the past few years, the metabolic health space has been buzzing due to a mix of increasing awareness, novel drugs and personalized ... having taken a GLP-1 medication. Twin Health — founded ...